The NRC's Human Health Therapeutics Research Centre could produce a vaccine developed by the American company Novavax once it has received the necessary regulatory approval.
Would you please tell us a little more about that?
Could you also tell us how the NRC manages its cooperative arrangement with its private-sector partners?